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The circadian clock regulates many aspects of immunity. Bacterial
infections are affected by time of day, but the mechanisms involved
remain undefined. Here we show that loss of the core clock protein
BMAL1 in macrophages confers protection against pneumococcal
pneumonia. Infected mice show both reduced weight loss and
lower bacterial burden in circulating blood. In vivo studies of
macrophage phagocytosis reveal increased bacterial ingestion fol-
lowing Bmal1 deletion, which was also seen in vitro. BMAL1−/−
macrophages exhibited marked differences in actin cytoskeletal or-
ganization, a phosphoproteome enriched for cytoskeletal changes,
with reduced phosphocofilin and increased active RhoA. Further
analysis of the BMAL1−/− macrophages identified altered cell mor-
phology and increased motility. Mechanistically, BMAL1 regulated a
network of cell movement genes, 148 of which were within 100 kb
of high-confidence BMAL1 binding sites. Links to RhoA function
were identified, with 29 genes impacting RhoA expression or acti-
vation. RhoA inhibition restored the phagocytic phenotype to that
seen in control macrophages. In summary, we identify a surprising
gain of antibacterial function due to loss of BMAL1 in macrophages,
associated with a RhoA-dependent cytoskeletal change, an increase
in cell motility, and gain of phagocytic function.
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The regular 24-h environmental cycle generated by the planet’srotation has led to the evolution of circadian rhythms in
virtually all life forms on Earth. These are driven by autonomous
cellular biological clocks, which coordinate physiology and be-
havior over the day–night cycle. In mammals, many physiological
systems are regulated in a time-of-day–dependent manner. In-
cluded in this, mammalian immunity is strongly regulated by the
circadian clockwork, driving the magnitude and nature of both
innate and acquired responses (1). Macrophages, in particular,
have a strong endogenous circadian clock, which drives inflam-
matory function (2–4). We have previously identified a role for
the circadian clock in regulation of time-of-day variation in
outcomes following pneumococcal infection (5), but the mech-
anisms responsible remain unknown.
The core cellular circadian pacemaker in mammals, oscillates
with a 24-h period, and consists of a positive arm, comprising
BMAL1/CLOCK heterodimeric transcription factors, which drive
transcription of the repressor genes period and cryptochrome. As
PERIOD and CRYPTOCHROME proteins accumulate, they
then inhibit BMAL1/CLOCK transactivation function. In addi-
tion, BMAL1/CLOCK drive expression of a second repressor
circuit consisting of the orphan nuclear receptors REVERBα, and
REVERBβ. These, in turn, repress Bmal1 gene expression. Beyond
the core circadian transcription–translation feedback loop the core
clock transcription factors act through clock-controlled genes
to regulate many aspects of physiology, including energy metab-
olism and immunity (6).
Many cells of the innate immune system have intrinsic clocks,
including monocytes, macrophages, neutrophils, mast cells,
eosinophils, and natural killer cells (2, 7–13). These cell-autonomous
rhythms drive aspects of differentiated cell function, including
cytokine production, trafficking, and phagocytosis. Within myeloid
cells the core circadian gene Bmal1 exerts a broad antiinflam-
matory effect, mediated to a large extent through its transcrip-
tional regulation of Reverbα, and Reverbß (3, 14, 15). Additional
direct Bmal1 effects in macrophages have also been identified (16,
17). For instance, specific bacterial infections show a time-of-day
dependence in outcome, including enteric Salmonella typhimurium
(18) and Streptococcus pneumoniae (5).
Infectious diseases are responsible for many deaths both in the
developed and developing world and, in the case of pneumonia,
are responsible for 5% of all deaths in the United Kingdom (19).
The emergence of multidrug-resistant bacteria makes it essential
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that we gain a better understanding of the mechanisms behind
infection, to identify new therapeutic strategies. The role of
circadian biology in bacterial pathogenesis has yet to be fully
explored. This is important, as several compounds now exist
which can alter key circadian pathways as well as repress or ac-
centuate circadian amplitudes. One of the key pathways gov-
erning the pathogenicity of an organism is phagocytosis.
Phagocytosis is the process of ingestion of large particles by
cells, based on rearrangement of the actin microfilament cyto-
skeleton. Macrophages and neutrophils are typical cells that fulfill
this function in mammals and are beneficial for host defense
against bacterial pathogens. Engulfment of the particle, through
cell-surface receptors for immunoglobulins, or complement, acti-
vates small GTP binding proteins of the Rho family, with speci-
ficity of downstream coupling. As an example RhoA is activated
by the complement receptor, but not the FcγR receptor. In its
active, GTP bound state, RhoA interacts with further downstream
effectors to drive F-actin reorganization. Previous work suggests
that ex vivo synchronized macrophages show time-of-day–
dependent changes in S. typhimurium phagocytosis and bacterial
killing (20). However, the role of the circadian clock and its
components in regulating phagocytosis, and the impact this has on
bacterial responses in vivo remains undefined. Here we identify a
significant gain in pneumococcal immunity resulting from loss of
the core clock protein BMAL1 in macrophages. This was accom-
panied by an increase in macrophage movement, and phagocytosis,
but not by a change in immune cell infiltration to the infected lung.
The most striking change was protection from bacteraemia (ex-
tension of the infection to the bloodstream). Further analysis
identified a gain in RhoA, and cofilin activity, accompanied by a
major reorganization in the actin cytoskeleton. This macrophage
gain-of-function phenotype was reversed by low concentrations of
the specific RhoA inhibitor CT04.
Results
Bmal1 Deletion Increases Resistance to Pneumococcal Pneumonia.
Previous work has identified circadian control of the lung inflam-
matory response to an acute challenge with aerosolized lipopoly-
saccharide (5). Furthermore, this study demonstrated variation in
the outcome from pneumococcal pneumonia (the most common
form of pneumonia) dependent on time of inoculation. Time of day
affects ex vivo phagocytic function of macrophages (21, 22), sug-
gesting a macrophage-autonomous circadian control of phagocytosis.
Therefore, to explore the role of the circadian clock within the
myeloid system in lung immunity against infection, we utilized mice
lacking the core clock component Bmal1 in myelomonocytic cells
(LysM-Bmal1−/− alveolar macrophage penetrance confirmed SI
Appendix, Fig. S1 A, Left) or macrophages (CX3CR1-Bmal1−/−, SI
Appendix, Fig. S1 A, Right) (Fig. 1 A and B). Both mouse lines
showed striking protection from bacteraemia (blood culture posi-
tive), 48 h after pneumococcal infection, but the LysM-Bmal1−/−
mice also showed reduced lung bacterial burden, and a trend toward
reduced bacteraemia was seen at 24 h following inoculation (SI
Appendix, Fig. S1B). There was no difference in total pulmonary
immune cellularity (Fig. 1C and SI Appendix, Fig. S1 C and D), nor
significant differences in peripheral blood proinflammatory cytokine
concentrations at 12 and 48 h postinfection (SI Appendix, Fig. S1E).
Taken together these findings suggest that the antibacterial efficacy
of each immune cell is greater, thereby preventing extension of the
infection to the bloodstream with similar numbers of effector im-
mune cells in the lung.
To test the idea that BMAL1 loss in macrophages provides
systemic protection from pneumonia, we also measured weight
loss, a measure of the systemwide impact of sepsis (Fig. 1D).
Mice lacking macrophage BMAL1 showed markedly less weight
loss than the littermate controls. Histological examination of the
affected lungs showed a similar immune cell infiltrate in both
genotypes, in accordance with the flow cytometry enumeration of
immune cells (Fig. 1E). NanoString measurement of inflammatory
mediator gene expression showed reduced proinflammatory cy-
tokines and increased expression of growth factors in animals
lacking macrophage BMAL1, indicating a proresolution state
compared to the littermate controls (Fig. 1F and SI Appendix, Fig.
S1F). The proposed reduction in inflammatory mediator expres-
sion in the lungs was further tested using a bead array to measure
protein concentrations in recovered lung tissue. There was a
general trend for lower concentrations of both pro and antiin-
flammatory cytokines, with CCL2, the monocyte chemokine, and
IL10, an important antiinflammatory cytokine, both showing a
significant reduction (Fig. 1G).
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Fig. 1. Deletion of BMAL1 in macrophages protects against pneumococcal
infection. (A) LysM-Bmal1−/− and (B) CX3CR1-Bmal1−/− mice (knockout [KO])
and floxed littermate controls (WT) were infected with S. pneumoniae at
ZT12. The bacterial load in lung and peripheral blood at 48 was quantified
(n = 8 to 12, Mann–Whitney U test *P < 0.05). (C) Immune cells were re-
covered from the lung tissue in A neutrophils, alveolar macrophages (AMs),
and interstitial macrophages (IMs). (D) Weight loss after 48 h (Mann–Whitney
U test *P < 0.05). (E ) Representative lung histology with H&E staining.
(Scale bar, 50 μm.) SPN, Streptococcus pneumoniae. (F) Cytokine analysis of
lung tissue from A was performed using a NanoString inflammatory gene
panel (see also SI Appendix, Fig. S1F). Each of the 248 genes is marked, and
those that statistically differ by genotype are marked in red, with gene
abbreviation. (G) Multiplex cytokine analysis of tissue from A (n = 8, t test,
exact P value marked, and *P ≤ 0.05).
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We have previously identified the orphan nuclear receptor
REVERBα as an obligate mediator of many of the inflammatory
effects resulting from BMAL1 loss in the macrophage (3). Ac-
cordingly we tested myelomonocytic disruption of the Reverbα
gene, using the reported DBDm strain crossed with LysM-cre
(23) (SI Appendix, Fig. S1G). Surprisingly, we saw no phenotype
in terms of bacterial outcome in lung, or in blood. Further, we
exposed wild-type (WT) animals to continuous light, which at-
tenuates circadian oscillations (24, 25). This also did not impact
outcomes to pneumococcal infection (SI Appendix, Fig. S1H).
Bmal1 Deletion Increases Phagocytic Function in Macrophages. To
test the intrinsic macrophage antibacterial activity, isolated
macrophages were incubated with a readily ingested bacterial
pathogen, pHrodo-transgenic Staphylococcus aureus (26). Due to
the inherent properties of the pHrodo dye, ingested bacteria
fluoresce when the phagosome fuses with the acidic lysosome
compartment (27). There was a significant increase in formation
of phagolysosomes, per macrophage, in response to Bmal1 de-
letion, both when tested in vivo through intraperitoneal (i.p.)
injection, or ex vivo, in culture (Fig. 2 A and B). Using live cell
imaging the kinetics of the response are clear. We can see iso-
lated macrophages responding to bacteria with phagocytosis and
observed greater phagocytosis at all time points, but with a sig-
nificant difference emerging even by 2 h postseeding. (Fig. 2 C–
E) (28). To investigate a possible role for secreted factors in
augmenting phagocytosis, we tested the impact of conditioned
medium from BMAL1-null macrophages, but this revealed no
effect, pointing to a cell-autonomous mechanism of BMAL1
action (SI Appendix, Fig. S2A). The impact of increased bacterial
ingestion is readily seen in fluorescent imaging, where enlarged
macrophages laden with fluorescent bacteria are seen in the
absence of BMAL1 (Fig. 2D).
We returned to study alveolar macrophages purified from the
lung and analyzed ex vivo using the optimized protocols de-
scribed above (Fig. 2F). Again, the increased ingestion of bac-
teria was seen in the absence of BMAL1, indicating this to be a
generalized macrophage phenotype. As some of our studies used
the LysM-cre driver, which also targets neutrophils, we purified
neutrophils from bone marrow and tested them in vitro, using
the same pHrodo-labeled S. aureus technology (Fig. 2G). Al-
though there was a trend for increased phagocytosis in the ab-
sence of BMAL1, this was not significant, and the magnitude of
effect was small. Therefore, the major driver of altered bacterial
response in BMAL1 deletion is the macrophage population.
Because the in vitro analysis used labeled S. aureus rather than S.
pneumoniae, we also tested phagocytosis of S. pneumoniae in
isolated macrophages in vitro using a gentamicin protection as-
say, and as with the S. aureus, we found this was increased in the
absence of BMAL1, indicating this is a more generalized anti-
bacterial property of the modified macrophages (Fig. 2H) result-
ing in increased phagocytosis. As these studies had revealed such a
striking impact of BMAL1 on macrophages, we tested the effect of
circadian phase on the macrophage phagocytic phenotype, as
previous reports had suggested differences dependent on circa-
dian phase. Here, we did see that phagocytosis was significantly
greater at zeitgeber time (ZT)12 compared to ZT0 (Fig. 2I).
We saw no impact of either disruption of the REVERBα DNA
binding domain, nor complete REVERBα deletion on isolated
macrophage phagocytosis (SI Appendix, Fig. S2B), supporting
the lack of in vivo pneumococcal infection phenotype. Further
analysis using the REVERB ligand GSK4112, which targets both
REVERB paralogs, had no effect on phagocytosis (SI Appendix,
Fig. S2C).
BMAL1 Expression Drives a Distinct Macrophage Phenotype. In an
unbiased gene expression analysis of 84 phagocytosis media-
tors, there was no difference seen under unstimulated conditions
between control and BMAL1-null peritoneal macrophages, and
both genotypes showed a similar major change in gene expres-
sion when activated (Fig. 3A). This suggests that the functional
B
800
1000
1200
1400
1600
*
A
0
2
4
6
Peritoneal 
macrophages
*
C
WT
KO
WT
KO
0 100 200 300
0
20
40
60
Time (minutes) 
Peritoneal macrophages
2 hour seed
0 100 200 300
0
50
100
150
Time (minutes) 
***
***
0 100 200 300
0
200
400
600
800
*
F Alveolar 
Macrophages
D
E
0
500
1000
1500
2000
Neutrophils
M
FI
 (a
u)
G
In vivo 
phagocytosis
WT KO
WT KOWT KO
- -+ +
- -+ +
37oC
  4oC
Fl
uo
re
sc
en
ce
 (a
u)
WT KOWT KO
- -+ +
- -+ +
37oC
  4oC
M
FI
 (a
u)
M
FI
 x
10
3  (
au
)
Time (minutes) 
Fl
uo
re
sc
en
ce
 (a
u)
WT
KO
WT
KO
Peritoneal macrophages
24 hour seed
Fl
uo
re
sc
en
ce
 (a
u)
Phagocytosis of 
S. pneumoniae
WT KO
0
1
2
3
4
lo
gC
FU
/m
l 
*
H
ZT0 ZT12
60
70
80
90
100
Fl
uo
re
sc
en
ce
 (a
u)
Time of Day
***
I
Fig. 2. BMAL1 deletion improves macrophage phagocytosis. (A) LysM-
Bmal1− /− mice and floxed controls were infected i.p. with S. aureus
pHrodo green (SAPG). Peritoneal exudate cells were sampled after 45 min
and subjected to FACS. The MFI was quantified (WT n = 5, LysM-Bmal1−/−
n = 4). *P < 0.05; Mann–Whitney U test. (B) Ex vivo phagocytosis assay. Peri-
toneal macrophages were incubated with SAPG for 4 h, before FACS analysis
(gating strategy see SI Appendix, Fig. S1D). (n = 3 mice) (Mann–Whitney U
test *P ≤ 0.05). Cells incubated with SAPG at 4 °C to inhibit enzymatic
function in the macrophages are also shown. (C–E ) Ex vivo live cell mi-
croscopy phagocytosis assays with representative combined brightfield and
fluorescence image. Peritoneal macrophages were recovered from LysM-
Bmal1−/− mice and floxed control mice, and seeded for (C and D) 2 h (WT,
n = 48) positions, LysM-Bmal1−/−, n = 57 positions, quantification and rep-
resentative fluorescent microscopy are shown. (Scale bar, 25 μm.) (E) At 24 h
(WT n = 25 positions, LysM-Bmal1−/− n = 30 positions). SAPG was added to
the cultures and the increase in MFI measured (mean and SEM plotted re-
peated measures ANOVA ***P < 0.0001). For representative FACS plot see SI
Appendix, Fig. S2D. (F) Alveolar macrophage live cell microscopy phagocy-
tosis assay. (n = 10 positions). (G) Ex vivo neutrophil phagocytosis assay. Bone
marrow-derived neutrophils from LysM-Bmal1−/− were plated in vitro and
subject to the same phagocytosis protocol as B. After 4 h, there was no
genotype effect (P = 0.2, Mann–Whitney U test). (H) Ex vivo S. pneumoniae
phagocytosis assay. Peritoneal macrophages were incubated with S. pneu-
moniae, D39. At 4 h after challenge, viable intracellular bacteria were
assessed (n = 8, Mann–Whitney U test *P ≤ 0.05). (I) Peritoneal macrophages
from C57BL/6 mice were subjected to live cell phagocytosis assay with la-
beled S. aureus at ZT0 and ZT12. (n = 36 to 38 wells per time of day) (Mann–
Whitney U test ***P < 0.0001).
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difference between the genotypes lies at the level of posttrans-
lational modification of the phagocytosis machinery, rather than
at the level of phagocytic gene expression. Phosphorylation is
known to play a major role in circadian control of physiology (29).
Therefore, we analyzed the phosphoproteomic changes between
BMAL1-null and control macrophages, and measured these
before and immediately after bacterial exposure. Here, we saw a
striking difference between the genotypes under resting condi-
tions, with a marked reduction in detected phosphosites in the
BMAL1-null macrophages (Fig. 3B), but negligible differences
remain after bacterial encounter (Fig. 3C). This is further illus-
trated by within-genotype analysis where the greatest difference
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Fig. 3. BMAL1 deletion in macrophages preactivates the cells. (A) Phagocytosis gene array in peritoneal macrophages using NanoString technology. Peri-
toneal macrophages were purified from LysM-Bmal1−/− and floxed littermate controls mice, and cultured in vitro for 24 h, and then 100 μg/mL S. aureus or
control media was added for 1 h. RNA was purified and analyzed by NanoString, using a phagocytosis panel (SI Appendix, Table S1). The principal component
analysis (PCA) plot comparing stimulated and control cells from both of the two genotypes is shown, with the LysM-Bmal1−/− (red) and floxed littermate
controls (blue). Each point represents an individual mouse. (B and C) Peritoneal macrophages from LysM-Bmal−/− and floxed littermate controls harvested at
ZT2 were cultured for 24 h and then treated with 100 μg/mL S. aureus for 30 min (stimulated) or vehicle control (unstimulated). Cells were harvested and
phosphopeptides purified. On the volcano plots, significant changes in identified phosphorylation sites are shown in red. Negative x axis values indicate lower in
BMAL1−/− cells (identified by ANOVA with post hoc test; n = 3). (D) RNA-Seq in unstimulated peritoneal macrophages. Magnitude-Average (MA) plot showing 454
genes with false discovery rate (FDR) < 0.01, in red. Cpm, counts per million. (E) Top IPA diseases and functions terms for the significant DE genes inD. (F) Enrichment
of RNA-Seq DE genes in relation to BMAL1 binding sites for different genomic distances from the center of the BMAL1 binding peaks. (G) Top 10 motifs found using
the BMAL1 peaks overlapping with DE genes at ±100-kb distance. (H) Top IPA diseases and functions terms for the 148 BMAL1 direct target genes.
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following stimulation is seen in the control cells compared to the
BMAL1-null macrophages, where macrophage activation prior to
stimulation means fewer phosphosites change following bacterial
stimulation (SI Appendix, Fig. S3A). Network analysis (SI Appen-
dix, Fig. S3B) highlights the major pathways involved in cell mo-
tility, and phagocytosis, including the actin cytoskeleton emerged
as differentially phosphorylated, and thereby activated, between
the genotypes (SI Appendix, Fig. S3C).
In order to identify how BMAL1 affects cell motility and
phagocytosis, we took an unbiased approach, purified peritoneal
macrophages, and ran RNA-Seq analysis, comparing the two
genotypes under resting conditions (Fig. 3D). The top gene on-
tology terms identified in differential gene expression analysis
were cell movement and migration of cells (Fig. 3E). Although
macrophage phagocytosis was delivered as a significant term it
was far less significant, suggesting that the macrophage motility
may be a dominant aspect of the phenotype rather than the
mechanics of bacterial engulfment, explaining the failure of the
original NanoString analysis to identify phagocytosis gene ex-
pression differences in the absence of BMAL1. Using Ingenuity
pathway analysis (IPA) (Qiagen), we identified the differentially
regulated genes within the cell movement pathway (Fig. 3 D and
E and Dataset S2). Next, we performed an integrative analysis of
the differentially expressed genes from the RNA-Seq and the
binding sites identified in previously published peritoneal mac-
rophage BMAL1 chromatin immunoprecipitation (ChIP)-Seq
dataset (30). Here, we extend BMAL1 binding sites in both di-
rections and extract the nearest coding genes. Taking these genes,
whose transcription start sites (TSSs) overlap with BMAL1 bind-
ing sites for a given genomic distance, we calculate statistical en-
richment of our differentially regulated geneset (those that change
in the BMAL1-null macrophages). In this way we identify strong
enrichment of our DE genes up to 100 kb from the BMAL1
binding sites after which the statistical significance declines (Fig.
3F). Therefore, we use the 100-kb distance cutoff either side of
BMAL1 binding sites, which gives us a 148-gene subset from our
DE geneset. Motif analysis of the corresponding BMAL1 peaks
produces multiple E-box motifs as top hits, as would be predicted
for BMAL1 binding sites (Fig. 3G). IPA analysis of these 148
genes found by using this integrative analysis in terms of diseases
and functions yields strong motility and phagocytosis-related terms
(Fig. 3H and Dataset S3).
Bmal1 Deletion Alters Actin Cytoskeletal Structures and Increases
Movement in Macrophages. As the actin cytoskeleton emerged
as a strong target for BMAL1 in macrophages, cell morphology
was examined more closely. There was a dramatic difference in
appearance, with loss of cortical actin, and marked cell rounding
seen in the BMAL1-null macrophages (Fig. 4 A and B and
Movies S1 and S2). This implies a more motile phenotype, and
indeed the BMAL1−/− cells moved a significantly greater dis-
tance when tracked in real time (Fig. 4 C and D and SI Appendix,
Fig. S4 A–D), without directionality. However, we did not see a
steady-state difference in G/F-actin ratio between the genotypes
(Fig. 4E). Macrophages exhibit coordinated migration along
chemokine gradients. In order to determine if the increased cell
motility was translated into greater velocity along a CCL2 che-
mokine gradient, we used a Boyden chamber chemotaxis assay
(Fig. 4F and SI Appendix, Fig. S4E). This did not show any ge-
notype difference, identifying a rather specific change in macro-
phage phenotype that was confined to motility, and which did not
impact migratory response to chemokine signal.
The RhoA signaling pathway is a major regulator of the actin
cytoskeleton and is activated in macrophages by complement-
opsonized bacteria via complement receptor 3. Therefore we
performed phagocytosis experiments with serum and analyzed
RhoA activity. Indeed, loss of BMAL1 markedly increased RhoA
activation under resting conditions (Fig. 5A). To investigate the
remodelling of the actin cytoskeleton further, we analyzed phos-
phocofilin, a major regulator of actin depolymerization, and
identified that the bacterial activation of macrophages decreased
phosphocofilin in control cells, but that in the BMAL1-null mac-
rophages phosphocofilin was already low (Fig. 5B). Overall our
data suggest that BMAL1 acts to maintain macrophages in a
quiescent state. When BMAL1 is removed, we see a change in
macrophage phenotype, with RhoA activation, a remodelled cy-
toskeleton, increased cell motility, and increased phagocytosis. To
test the idea that basal induction in RhoA is sufficient to prime
BMAL1-null macrophages for enhanced bacterial phagocytosis,
we used a RhoA inhibitor (CT04) (31). In this study the inhibitor
was titrated into a phagocytosis assay, and the impact measured.
Again, we observed the basal increase in phagocytosis in the
BMAL1-null macrophages, but now see that this is reduced to the
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Fig. 4. BMAL1 deletion alters macrophage morphology and motility. (A and
B) Peritoneal macrophages from LysM-Bmal1−/− and floxed littermate con-
trols. Live cell imaging with ultraresolution confocal microscopy, using
Airyscan detector showing F-actin. (Scale bar, 10 μm.) (C and D) Macrophages
were also tracked through spontaneous migration for 4 h using a Livecyte
kinetic cytometer (phasefocus). The distance moved and direction are rep-
resented in the rose plots. Mean step length WT 3.81 μm, and KO 5.04 μm;
median step length WT 2.24 μm, and KO 3.61 μm; unpaired t test, P value <
0.0001 (cell number WT n = 683, KO n = 870 combination of cells from 12
wells per genotype). (E) Macrophages (WT and KO) were cultured for 72 h
postrecovery from animals before lysis and analysis of globular and fila-
mentous actin. The different molecular forms were quantified by immuno-
blot and plotted. There was no genotype effect. (F ) Transwell migration
assay. Peritoneal macrophages were cultured in vitro at 1 × 105 cells per 24-
well plate in a Transwell insert. Migration across the membrane toward CCL2
at 500 ng/μL was quantified using crystal violet staining after 4 h (Mann–
Whitney U test; NS P > 0.05).
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level of wild-type activity in the BMAL1-null macrophages in re-
sponse to low-dose RhoA inhibition, at a concentration insuffi-
cient to affect wild-type cells (Fig. 5C). At higher concentrations
both genotypes of macrophages show a reduction in bacterial in-
gestion, with no genotype differences.
We investigated the downstream mediators of activated small
GTPases in the targeted macrophages and, informed by the
analysis of phosphoproteins (SI Appendix, Fig. S3C), saw a marked
increase in basal expression of WAVE2 (Fig. 5D), an essential link
between the GTPases and Arp2/3 regulation of actin branching,
and polymerization, providing further evidence of a remodelled
actin control machinery. Having identified a strong signal for
differential activity in pathways affecting the actin cytoskeleton
and Rho GTPases in the phosphoproteome analysis (SI Appendix,
Fig. S3C), and discovering that cell movement was identified as
the most significant “diseases and functions” term in the tran-
scriptome (Fig. 3E) analysis, we next looked to identify regulatory
links between BMAL1 and RhoA. The IPA term “cell movement”
was delivered with 164 genes found to be differentially regulated.
Of these genes, 29 genes have functional links to RhoA in IPA (SI
Appendix, Fig. S5), with 8 of these genes also being located within
100 kb of high-confidence BMAL1 peaks (30) (Fig. 5E and SI
Appendix, Fig. S5).
Discussion
Despite recent advances in understanding about circadian control
of the immune system, relatively little is known of how antibac-
terial responses are subject to temporal gating. We now show a
surprising gain of macrophage function following deletion of
BMAL1, resulting in significant reduction in pneumococcal in-
vasion. This protection appeared driven by increased macrophage
motility and phagocytic function. The effect was confined to the
macrophage and not seen in neutrophils. Further analysis identi-
fied changes in RhoA, and cofilin activity resulting from BMAL1
loss, and a major reorganization of macrophage cytoskeletal actin.
We used a RhoA inhibitor to investigate function further and
observed that very low concentrations, insufficient to impact on
wild-type cells, were sufficient to bring down the phagocytosis rate
to that seen in wild-type cells, supporting an important role for
RhoA activation in the phagocytic gain-of-function phenotype.
Many immune cell types have intrinsic circadian clock activity,
leading to time-of-day variation in response (1). Among the im-
mune responses lying under circadian control are acute inflam-
mation, lethality in response to endotoxic shock, allergic reactions,
cytokine release, and macrophage phagocytosis (2, 3, 32–34).
Susceptibility of mice to infection with Listeria monocytogenes, S.
typhimurium, and S. pneumoniae all show a daily rhythm, suggest-
ing a fundamental role for the circadian clock in bacterial defense
(5, 7, 18).
A number of cell types and mechanisms have been proposed
as mediating temporal control of inflammation and antibacterial
response, including barrier epithelium, and cells of the innate
immune response, including neutrophils, Ly6Chi monocytes, and
resident tissue macrophages (3, 5, 7). Previous attempts to an-
alyze circadian control of phagocytosis have led to conflicting
results. Oliva-Ramírez et al. observed small effect sizes and weak
circadian rhythmicity in isolated cells, and all circadian signals
were lost in freshly isolated macrophages recovered at different
times (20). In contrast, Geiger et al. found only ex vivo differ-
ences in phagocytosis, but no effects in vivo (21). Therefore, the
role of the clock in phagocytosis remains undefined, and the
mechanistic links remain undetermined. As we had previously
observed striking temporal regulation of pneumococcal pneu-
monia, which was not explained by Bmal1 deletion in the club
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cell, we returned to this model to determine how myeloid
timekeeping impacted macrophage antibacterial function. In our
studies of macrophages, we have used two cre driver lines: LysM
and CX3CR1. Although the CX3CR1 driver has the major ad-
vantage of not targeting neutrophils it has been reported to
target gene deletion in other myeloid cell types, including mast
cells, dendritic cells, and natural killer (NK) cells (35). However,
these cell types do not play a prominent role in acute bacterial
infections.
The striking observation that loss of the central clock gene
Bmal1 resulted in a major protective effect against bacteraemia
in pneumococcal pneumonia was unexpected, as most circadian
disruptions impair fitness. Further analysis suggested the effect
was due to enhanced motility and phagocytosis, with cells ingesting
more bacteria. The effect was confined to macrophages, and not
seen in neutrophils, despite similar molecular mechanisms of ac-
tion. However, macrophages have a strong endogenous clock,
coupled to inflammatory signaling cascades, and in neutrophils,
timekeeping is driven in part by the vasculature through chemo-
kine actions, and also in part by the actions of BMAL1 driving a
gene expression program which affects cellular senescence, tissue
migration, and state of inflammatory activation (9, 13). It is im-
portant to note that our data revealing the response to pneumo-
coccal infection are surprising, as previously work has shown that
loss of BMAL1 in the myeloid lineage results in increased in-
flammatory responses to bacterial mimics, such as lipopolysac-
charide (3). In addition, previous work has shown an increased risk
of death from sepsis in response to listeria bacterial infection,
when administered by i.p. injection (7), probably resulting from
increased cytokine production driving a septic shock phenotype.
The key difference here is the sublethal infectious inoculum, ad-
ministered to the lung, which permits elaboration of an effective
immune response, and under these circumstances the gain-of-
function macrophage phagocytosis phenotype offers a significant
host advantage. The cytokine measurements at 48 h in our model
fit with the reduced bacterial burden and mark a move to reso-
lution of the infection.
The discovery of BMAL1-dependent RhoA activation and
cytoskeletal actin remodelling is reminiscent of the RhoA changes
seen in epithelial/fibroblast cells following circadian manipulation,
with impacts on wound healing kinetics (31). Similar cross-
coupling between actin dynamics and circadian machinery was
reported by Schibler and colleagues, suggesting a signaling pathway
from serum response factor through G/F actin to affect circadian
phase, and reciprocal signaling contributing to timing of mitosis
(28). In our analysis we discovered a widespread reprogramming
of cell motility and cytoskeletal gene expression in response
to macrophage deletion of BMAL1. This, coupled with the lack
of a chemokine directional migration phenotype, suggests
the primary mechanism for the phagocytic phenotype is en-
hanced motility, following loss of organized, cortical actin in the
macrophages.
Taken together, we report a gain in macrophage function
following deletion of the core clock protein BMAL1, and reveal
a mechanism in which BMAL1 acts as a repressor of the immune
system, operating as a “brake,” regulating the magnitude of
phagocytosis responses following infection. This was not seen with
REVERBα manipulation and could not be replicated by physio-
logical circadian manipulations using ambient light changes, al-
though this environmental manipulation may not have sufficiently
impacted the macrophage circadian clock to detect an effect. In
the absence of BMAL1 expression, REVERBα is greatly reduced,
and the cells lack circadian rhythmicity, but in contrast, in the
absence of REVERBα, BMAL1 expression is high, and the cells
remain circadian rhythmic. Although we previously showed that
the exaggerated cytokine responses seen in airway epithelium lack-
ing BMAL1 are phenocopied by disruption of REVERBα, here
we document a BMAL1-dependent and REVERBα-independent
pathway regulating macrophage migration and phagocytosis.
Thus, these two clock proteins have separate but interlocked
functions in the elaboration of an inflammatory response, regu-
lating cytokine release and local tissue neutrophilia (REVERB
dependent) and macrophage phagocytosis behavior (BMAL1
dependent). We have previously shown that acute TLR-4–
mediated cytokine responses to LPS are mediated by rapid
degradation of the repressor REVERBα protein [14]. An im-
plication from our current studies, and yet to be tested, is that
following infection, enhanced phagocytosis may also be mediated
by a similar rapid degradation of BMAL1 protein in macrophage
cells. Here we cannot rule out that loss of both REVERBα and
REVERBβ may replicate the BMAL1 loss, but equally the BMAL1
effect may be mediated by a non-REVERB pathway, one that relies
on direct action of BMAL1 on motility and cytoskeletal gene ex-
pression. Indeed, BMAL1 binding was detected close to key mo-
tility effector genes, supporting direct BMAL1 regulation.
The circuit involving cytoskeletal actin reorganization has
been linked to the circadian clock before, in fibroblasts, but now
we find that this confers BMAL1 control to macrophage motility
and phagocytosis. The translational implications are clear, with
targeted interventions to replicate the macrophage gain of
function being attractive approaches to treat prevalent infectious
diseases.
Materials and Methods
Animals. Colonies of LysM-Bmal1−/−, LysM-Rev-Erbα-DBDm, and CX3CR1-
Bmal1−/− mice were maintained in the University of Manchester Biological
Services Facility (BSF). Where WT-only mice were used, C57BL/6 were pur-
chased from Envigo. All genetically modified mice were created on a C57BL/
6 background and housed in 12:12 light/dark (L:D) cycles with food and
water supplied ad libitum. All protocols were approved by the University of
Manchester Animal Welfare and Ethical Review Body, and the Animals
(Scientific Procedures) Act 1986 UK Home Office guidelines were strictly
adhered to. Conditional targeted cre-positive mice were sex and age
matched with floxed/floxed littermate controls; females aged 10 to 14 wk
were used for in vivo experiments and peritoneal exudate cells (PECs) for ex
vivo were harvested from male mice. Genotyping was performed on all
experimental animals.
S. pneumoniae Infection. Mice were infected at ZT12 with S. pneumoniae
(serotype 2, strain D39) (National Collection of Type Cultures [NCTC] 7466),
intranasally with 1 × 106 colony-forming units (CFU) per mouse in 20 μL
phosphate buffered saline (PBS) under isoflurane anesthesia. Animals were
killed 24 or 48 h later. Blood was collected from the femoral artery (into
1:20 heparin). Two methods of lung tissue preparation were used, lung
tissue digest and lung homogenate. Lung tissue digest was prepared by
digesting minced tissue in a solution of 0.154 mg/mL collagenase I and II (Liberase
TM, Roche 05401127001) and 50 μg/mL DNase I (Roche 11284932001). After 30min
at 37 °C, the reaction was stopped with ethylenediaminetetraacetic acid
(EDTA) and the digest passed through a 70-μM filter. Homogenate was
prepared in Rhino tubes together with six 3.2-mm ball bearings. Tubes
were placed in a Storm Bullet blender for 5 min on setting 8. Whole blood
and lung homogenate were plated out on Columbia blood-agar plates in
serial dilution overnight at 37 °C and CFUs counted the next day.
Primary Cell Culture. Cells were collected frommice by peritoneal lavage. PECS
were isolated, resuspended in complete Roswell Park Memorial Institute
culture medium (RPMI) and seeded at 3 × 105 cell/cm2. Cells were washed in
media and then used in experiments. For neutrophils, bone marrow was
harvested with neutrophils being extracted using the neutrophil enrichment
kit (STEMCELL Technologies). Alveolar macrophages were harvested by in-
stilling 1 mL PBS via the trachea into the lungs and this process was repeated
three times.
Phagocytosis Assays. Different types of phagocytosis assay were used in these
studies, in vivo, ex vivo, fixed time point, real-time live cell microscopy, and
plate reader.
In Vivo Phagocytosis Assay. Mice were injected i.p. with 10 μg (in 200 μL)
attenuated S. aureus expressing pHrodo green (SAPG). The PECs were har-
vested and washed twice in PBS and resuspended in FACS buffer (PBS, 2%
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[bovine serum albumin] 0.1% sodium azide). Samples with excess blood
contamination were excluded from the analysis. Flow cytometry was per-
formed immediately on a BD FACS CANTO flow cytometer. Debris was gated
out and geometric mean measured in the fluorescein isothiocyanate (FITC)
fluorescence channel.
Flow Cytometry. A single-cell suspension was generated from pulmonary
digest to enable characterization of the pulmonary infiltrate during pneu-
mococcal infection. A live/dead marker was first applied (LifeTechnologies
L10119; 1:1,000) in PBS. Antibodies and blocker were made up in FACS buffer
(PBS, 2%BSA, and 0.1% sodium azide): Fc receptors were blocked (1:100; anti-
CD16/32, eBioscience 14-0161). Antibodies were incubated for 25 min at 4 °C.
We used CD11b-PerCPCy5.5 (1:200; clone M1/70, 45-0112), CD11c-APC (1:400;
clone N418, 17-0114), Ly6G-FITC (1:100; clone RB6-8C5, 11-5931), and F4/80-
PE-Cy7 (1:200; clone BM8, 25-4801) (all eBioscience). After washing, cells
were resuspended in 50 μL 1% PFA for 20 min at room temperature (RT).
Cells were washed, resuspended in FACS buffer, and analysis was carried out
on a BD FACS CANTO flow cytometer. Neutrophils were identified as
f4/80−CD11b+Ly6G+. Alveolarmacrophageswere identified as F4/80+CD11c+CD11blo.
Interstitial macrophages were identified as F4/80+CD11c−CD11bhi.
Fixed Time Point Phagocytosis Assay. PECS were seeded at 5 × 105 cells per
well in a 24-well plate. After washing, cells were incubated in fresh complete
RPMI with 0.1 mg/mL SAPG. Targeted cells and floxed controls were in-
cubated at 37 °C and in a separate plate at 4 °C. After 4 h, phagocytosis was
stopped with ice-cold PBS wash and cells were detached with 200 μL 1×
trypsin EDTA (Sigma) at 37 °C for 15 min, confirmed by microscopy. Cells
were washed twice and resuspended in FACS buffer. Flow cytometry was
performed immediately on a BD FACS CANTO flow cytometer and mean
fluorescent intensity (MFI) was quantified in the FITC channel.
Real-Time Live Cell Microscopy. PECS were seeded at 5 × 105 cells per well in a
24-well plate. Fresh RPMI (Sigma) with 10% FBS (Life Technologies) and 1%
penicillin/streptomycin (Sigma) was applied. S. aureus pHrodoGreen (SAPG)
0.1 mg/mL was added at time 0. Multiple images were acquired on an Eclipse
Ti inverted microscope (Nikon), 20× objective and the Nikon green LED FITC
channel. A Retiga R6 camera captured the images and the imaging software
used was NIS Elements AR (Nikon). Point visiting was used to allow multiple
positions to be imaged within the same time course and cells were main-
tained at 37 °C and 5% CO2. Nd2 image files were extracted to TIFF stacks
and processed in ImageJ (NIH). The fluorescent intensity in each position was
quantified in the green channel in every visual field at every time point. The
average value for each genotype was then plotted against time.
Ex Vivo S. pneumoniae Phagocytosis (Gentamicin Protection Assay). Peritoneal
macrophages were infected with pneumococci opsonized with complement
(from whole mouse serum) to enhance adherence at a multiplicity of in-
fection (MOI) of 10, incubated at 4 °C for 1 h (to maximize adherence), and
then at 37 °C for 3 h (to allow internalization by macrophages) (36). Cultures
were washed 3 times in PBS to remove nonadherent bacteria. The cells were
then incubated with benzyl-penicillin and gentamicin to kill remaining ex-
tracellular bacteria, as described. The cells were lysed in saponin and live
intracellular bacteria quantified by the Miles Misra method (37).
Plate Reader Phagocytosis Assay. PECS were seeded into a 96-well plate and
incubated with 50 μg SAPG. Fluorescence was measured using a Promega
Glow max multi detection reader. For the RhoA inhibition prior to phago-
cytosis, cells were treated with RhoA inhibitor CT04, (Cytoskeleton Inc.) or a
vehicle control 2 h before phagocytosis assay with SAPG.
Nano-String Gene Array. Peritoneal macrophages were incubated with heat-
treated S. aureus (wood strain, without protein A) for 1 h. The Promega
Reliaprep cell miniprep system (TM370) was used to lyse cells and extract
RNA. RNA quality was assessed via Agilent RNA TapeStation. The concentra-
tion of the RNA was quantified using a Qubit and the sample concentration
was adjusted to 20 ng/μL in 10 μL. The RNA was then run on a NanoString
nCounterTM (NanoString Technologies) in conjunction with a custom panel of
phagocytosis genes.
RNA-Seq. PECS from LysM-Bmal1−/− and littermate controls (n = 5) were
seeded at 5 × 105 cells per well in a 24-well plate. After washing peritoneal
macrophages were lysed and RNA was extracted with ReliaPrep RNA cell
miniprep (Promega). RNA quality was assessed using 4200 Tapestation
(Agilent Technologies) and all RNA integrity number (RIN) values were >9.0.
Unmapped paired-end sequences from an Illumina HiSeq4000 sequencer
were tested by FastQC (http://www.bioinformatics.babraham.ac.uk/projects/
fastqc/). Sequence adapters were removed and reads were quality trimmed
using Trimmomatic_0.36 (38). The reads were mapped against the reference
mouse genome (mm10/GRCm38) and counts per gene were calculated using
annotation from GENCODE M21 (www.gencodegenes.org/) using STAR_2.5.3
(39). Normalization, principal component analysis, and differential expres-
sion were all determined with DESeq2_1.24.0 (40).
To calculate enrichment of our set of differentially expressed genes (padj<
0.01) with respect to BMAL1 ChIP-Seq data, we used publicly available
macrophage BMAL1 ChIP-Seq data from the Cistrome database [Oishi et al.
(30), LPS 0 h], and we extracted genesets whose TSSs overlap with BMAL1
peaks for different genomic distances, i.e., ±2 kb to ±1 Mb in seven bins, from
the center of the peak. For each such geneset, corresponding to a given
genomic distance, a hypergeometric P value was calculated for its in-
tersection with the RNA-Seq DE genes, with total number of genes in the
genome (mm10) as background.
Western Blotting. Total cell protein was isolated from cells using lysis buffer
(50 mM Tris, 150 mM NaCl, 1% Triton X-100, 0.2% SDS, supplemented with
protease inhibitors). Equal protein quantities were run on an SDS 4 to 20%
TGX miniprotean TGX stain-free protein gel (Bio-Rad) and transferred to
low fluorescence PVDF membrane (Bio-Rad) via the Trans-Blot Turbo
transfer system (Bio-Rad). Membranes were blocked with Odyssey blocking
buffer (Li-Cor) for 1 h at room temperature. Samples were probed with anti-
body overnight at 4 °C (BMAL1-D2L7G, Cell Signaling Technologies 14020).
Immunoreactivity was visualized using the Odyssey CLx near-infrared imaging
system and fluorescence quantified in ImageStudioLite (Li-Cor).
G-Actin/F-Actin Ratio. Expression of G and F actin was determined using the
G-actin/F-actin In Vivo Assay Kit by Cytoskeleton, used according to the
manufacturer’s instructions (BK037). The protocol separates filamentous
from globular actin by ultracentrifugation before detection by immunoblot.
RhoA Activation Assay. RhoA activity wasmeasured using the RhoAActivation
Assay Biochem Kit by Cytoskeleton, performed according to the manufac-
turer’s instructions (BK036).
Transwell Migration Assay. The 24-well Millicell hanging cell culture inserts
(Millipore, MCEP24H48, 8-μm pore) were seeded with 1 × 105 peritoneal mac-
rophages, index wells were treated with 500 ng/mL CCL2 (R&D Systems), and
incubated for 4 h. Cells were fixed in 4% PFA for 15min at RT. Nonmigrated cells
were removedwith a cotton swab. Cells were stained with crystal violet (5 mg/mL
in 2% ethanol) for 30 min at RT. The inserts were washed twice in PBS and
excess stain was removed mechanically from the upper side of the membrane.
Migrated cells were solubilized in 2% SDS overnight at room temperature and
absorbance was read at 560 nm (Glomax plate reader, Promega).
Migration Microscopy. Label-free quantitative phase images were generated
via Livecyte’s automated Acquire software and Ptychographic reconstruction
algorithm. Cells were imaged with a 20× objective lens every 10 min. During
imaging, cells were maintained in an environmental chamber at 37 °C with
5% CO2 and 95% humidity. Cell tracking was performed automatically with
Livecyte Analyze software. Single-cell migration metrics: cell speed and track
length, were exported from Analyze and plotted.
Data Availability Statement. RNA-Seq data that support the findings of this
study have been deposited in ArrayExpress, https://www.ebi.ac.uk/arrayexpress/,
with the accession code E-MTAB-8411 (41).
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